Trevena, Inc. CEO To Present At The 9th Annual JMP Securities Healthcare Conference

Published: Jun 18, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Trevena, Inc. (NASDAQ:TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that Maxine Gowen, Ph.D., its president and chief executive officer, will present at the 9th Annual JMP Securities Healthcare Conference on Wednesday, June 25, 2014 at 11:00 a.m. EDT at The Westin Grand Central in New York City.

Help employers find you! Check out all the jobs and post your resume.

Back to news